News

The Kansas City Business Journal spoke to Dr. Tim Pluard about Saint Luke's Cancer Institute's expansion of services for patients battling cancer in the Northland.

Saint Luke's Cancer Institute is expanding in the Northland with more services being offered at Saint Luke's North Hospital–Barry Road for patients battling cancer.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.

Dr. Furha Cossor is a cancer survivor herself and she is going beyond the walls of the hospital to fight cancer.

Consumer Reports On Health talked to Dr. Bethany Austin and Austin Workman about strategies to improve quality of life for those living with heart failure.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.

Saint Luke’s Mid America Heart Institute today announced results from the STEP HFpEF DM trial.

During Heart Month, we are talking about the risks of undiagnosed heart failure and treatment options for those with heart failure.

FOX4 talked to Ted Perez and his heart transplant surgeon, Dr. Russ Davis, about the lifelong Chiefs fan's incredible story.